July 30, 2016 2:13 PM ET

Biotechnology

Company Overview of GlobeImmune Inc.

Key Executives for GlobeImmune Inc.

NameBoard RelationshipsTitleAge
Timothy C. Rodell M.D., Jr.17 RelationshipsChief Executive Officer, President and Director65
Donald Bellgrau Ph.D.17 RelationshipsScientific Founder and Chairman of The Scientific Advisory Board--
Richard C. Duke Ph.D.80 RelationshipsScientific Founder and Member of Scientific Advisory Board--
C. Jeffrey Dekker CPANo RelationshipsVice President of Finance, Treasurer and Secretary51
Thomas A. Keuer 14 RelationshipsActing Head of Manufacturing Operations57

GlobeImmune Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
J. William Freytag Ph.D. 58 RelationshipsGlobeImmune Inc.64
Timothy C. Rodell M.D., Jr. 17 RelationshipsGlobeImmune Inc.65
Richard C. Duke Ph.D. 80 RelationshipsGlobeImmune Inc.--
Donald Bellgrau Ph.D. 17 RelationshipsGlobeImmune Inc.--
Daniel J. Mitchell 128 RelationshipsSequel Venture Partners59
View All Board Members

GlobeImmune Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee S. Edward Torres34 Relationships3 Executives
Compensation Committee Ph.D.J. William Freytag58 Relationships2 Executives
Nominating Committee Daniel J. Mitchell128 Relationships2 Executives
Corporate Governance Committee Daniel J. Mitchell128 Relationships2 Executives
Advisory Board Ph.D.Donald Bellgrau17 Relationships13 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary$405.0K
405.0K
380.7K
Bonus
Not meaningful
Total Short Term Compensation$405.0K
405.0K
475.3K
Total Value of Options
34.0M
Compensation as of Fiscal Year
GlobeImmune Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

TRACON Pharmaceuticals, Inc. Announces Resignation of Ronald Shazer as Chief Medical Officer, Effective August 5, 2016
July 29, 2016 8:02 PM ET
Editas Medicine, Inc. Names Akshay Vaishnaw to the Board of Directors
July 29, 2016 12:00 PM ET
Spring Bank Pharmaceuticals, Inc. Appoints Todd C. Brady to the Company's Board of Directors
July 28, 2016 8:05 PM ET
U.S. Stem Cell, Inc. Announces Resignation of Sam Ahn as Member of the Board of Directors
July 28, 2016 8:03 PM ET
Provista Diagnostics Appoints Judith K. Wolf as Chief Medical Officer
July 28, 2016 1:00 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact GlobeImmune Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.